These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3220459)

  • 21. Assessment of quality of life in recently post-menopausal women on dopaminergic therapy for pathological hyperprolactinaemia.
    Giusti M; Foppiani L; Penati S; Marugo A; Montini P; Menichini U; Rasore E; Giordano G
    Minerva Endocrinol; 1999 Mar; 24(1):11-9. PubMed ID: 10731741
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hyperprolactinaemia does not always mean 'hyperprolactinaemia'!
    Gezer A; Atasü T; Hekim C; Stenman UH; Hekim N
    Eur J Obstet Gynecol Reprod Biol; 2005 Feb; 118(2):206-8. PubMed ID: 15653204
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Variations in prolactin secretion in hyper- and normoprolactinaemia with or without galactorrhoea.
    Godo G; Koloszar S; Daru J; Falkay G; Sas M
    Acta Med Hung; 1989; 46(1):43-51. PubMed ID: 2771583
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bone mineral content of the hyperprolactinemic rat femur by single photon absorptiometry.
    Fiore CE; Clementi G; Prato A; Foti R; Conforto G
    Horm Metab Res; 1988 Jan; 20(1):40-3. PubMed ID: 3371856
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mineral content of skeletal bones in otosclerosis.
    Jensen KJ; Nielsen HE; Elbrønd O; Hansen HH
    Clin Otolaryngol Allied Sci; 1979 Oct; 4(5):339-42. PubMed ID: 487632
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frequency of hyperprolactinaemia due to large molecular weight prolactin (150-170 kD PRL).
    Bjøro T; Mørkrid L; Wergeland R; Turter A; Kvistborg A; Sand T; Torjesen P
    Scand J Clin Lab Invest; 1995 Apr; 55(2):139-47. PubMed ID: 7667607
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyperprolactinaemia and reproductive failure.
    Gunaratne M
    Ceylon Med J; 1993 Dec; 38(4):181-3. PubMed ID: 8143334
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sub-clinical hypothyroidism in infertile Nigerian women with hyperprolactinaemia.
    Emokpae MA; Osadolor HB; Omole Ohonsi A
    Niger J Physiol Sci; 2011 Nov; 26(1):35-8. PubMed ID: 22314984
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of prolactin and estrogen deficiency in amenorrheic bone loss.
    Klibanski A; Biller BM; Rosenthal DI; Schoenfeld DA; Saxe V
    J Clin Endocrinol Metab; 1988 Jul; 67(1):124-30. PubMed ID: 3379129
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Skeletal involvement in female acromegalic subjects: the effects of growth hormone excess in amenorrheal and menstruating patients.
    Scillitani A; Chiodini I; Carnevale V; Giannatempo GM; Frusciante V; Villella M; Pileri M; Guglielmi G; Di Giorgio A; Modoni S; Fusilli S; Di Cerbo A; Liuzzi A
    J Bone Miner Res; 1997 Oct; 12(10):1729-36. PubMed ID: 9333135
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patients with macroprolactinaemia: clinical and radiological features.
    Donadio F; Barbieri A; Angioni R; Mantovani G; Beck-Peccoz P; Spada A; Lania AG
    Eur J Clin Invest; 2007 Jul; 37(7):552-7. PubMed ID: 17576206
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of aging on the bone mineral content. Part III. The difference in the loss of bone mineral with aging between male and female].
    Shiraki M; Ito H; Hatano S; Shichida K; Sugiura M; Suzuki Y; Orimo H; Yamashita G
    Nihon Ronen Igakkai Zasshi; 1984 Jan; 21(1):8-13. PubMed ID: 6737774
    [No Abstract]   [Full Text] [Related]  

  • 33. Prolactin levels in infertility and bromocriptine therapy in hyperprolactinaemia.
    Prathibha D; Govardhani M; Krishna PT
    J Indian Med Assoc; 1994 Dec; 92(12):397-9. PubMed ID: 7876578
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Importance of cannulated prolactin test in the definition of hyperprolactinaemia.
    Whyte MB; Pramodh S; Srikugan L; Gilbert JA; Miell JP; Sherwood RA; McGregor AM; Aylwin SJ
    Pituitary; 2015 Jun; 18(3):319-25. PubMed ID: 24879500
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of serum PRL bioactivity evaluation in hyperprolactinaemic women with different menstrual disorders.
    Kostrzak A; Warenik-Szymankiewicz A; Meczekalski B
    Gynecol Endocrinol; 2009 Dec; 25(12):799-806. PubMed ID: 19905999
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Should macroprolactin be measured in all hyperprolactinaemic sera?
    McKenna TJ
    Clin Endocrinol (Oxf); 2009 Oct; 71(4):466-9. PubMed ID: 19320649
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bone mineral status in childhood accidental fractures.
    Chan GM; Hess M; Hollis J; Book LS
    Am J Dis Child; 1984 Jun; 138(6):569-70. PubMed ID: 6720643
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bone mineral content in chronic renal failure and after renal transplantation.
    Dalén N; Alvestrand A
    Clin Nephrol; 1973; 1(6):338-46. PubMed ID: 4594997
    [No Abstract]   [Full Text] [Related]  

  • 39. Plasma levels of parathyroid hormone-related peptide are elevated in hyperprolactinemia and correlated to bone density status.
    Stiegler C; Leb G; Kleinert R; Warnkross H; Ramschak-Schwarzer S; Lipp R; Clarici G; Krejs GJ; Dobnig H
    J Bone Miner Res; 1995 May; 10(5):751-9. PubMed ID: 7639111
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hyperprolactinaemia increases intraocular pressure in humans.
    Drago F; Cavallaro N; Dal Bello A; Cavaliere S; Spampinato D; Gorgone G
    Metab Pediatr Syst Ophthalmol (1985); 1987; 10(3):76-8. PubMed ID: 3431424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.